72 related articles for article (PubMed ID: 10203220)
21. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
22. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
Muirhead DM; Hoffman HT; Robinson RA
J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
[TBL] [Abstract][Full Text] [Related]
23. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
[TBL] [Abstract][Full Text] [Related]
24. Fas and WAF1 expression in esophageal squamous cell carcinomas.
Vlachos K; Siafakas N; Karameris A; Athanasas G; Theodoropoulos G; Parassi E; Peros G; Papadopoulos J; Hakim N
Int Surg; 2006; 91(6):320-5. PubMed ID: 17256429
[TBL] [Abstract][Full Text] [Related]
25. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
Chen YK; Hsue SS; Lin LM
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
[TBL] [Abstract][Full Text] [Related]
26. Fas expression and Fas monoclonal antibody-induced apoptosis in a human squamous cell carcinoma cell line, SCC-25.
Seta C; Fujita M; Muraki Y; Fukuda J; Kobayashi S; Haneji T
J Oral Pathol Med; 2000 Jul; 29(6):271-8. PubMed ID: 10890558
[TBL] [Abstract][Full Text] [Related]
27. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
Bhawal UK; Sugiyama M; Nomura Y; Kuniyasu H; Tsukinoki K
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1055-9. PubMed ID: 18936350
[TBL] [Abstract][Full Text] [Related]
28. Fas-Fas ligand pathway does not actively work in extrahepatic bile duct carcinoma.
Ito Y; Takeda T; Sakon M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(3B):1999-2003. PubMed ID: 10928141
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
30. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
31. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
[TBL] [Abstract][Full Text] [Related]
32. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
[TBL] [Abstract][Full Text] [Related]
33. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas.
Landesberg R; Woo V; Huang L; Cozin M; Lu Y; Bailey C; Qu W; Pulse C; Schmidt AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):617-24. PubMed ID: 18206396
[TBL] [Abstract][Full Text] [Related]
34. Expression of Fas and Fas ligand in primary cutaneous squamous cell carcinoma in association with grade of tumor differentiation.
Lee YB; Kyung Kim E; Park HJ; Cho BK; Park YM; Kim JW; Yoo NJ; Park YG; Oh ST
Int J Dermatol; 2013 Sep; 52(9):1092-7. PubMed ID: 23045958
[TBL] [Abstract][Full Text] [Related]
35. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma.
Nagi C; Xiao GQ; Li G; Genden E; Burstein DE
Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123
[TBL] [Abstract][Full Text] [Related]
37. Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis.
Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kouzu Y; Koike H; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
Hum Pathol; 2009 Jan; 40(1):83-91. PubMed ID: 18789482
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
[TBL] [Abstract][Full Text] [Related]
39. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
40. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue.
Ro Y; Muramatsu T; Shima K; Yajima Y; Shibahara T; Noma H; Shimono M
Int J Oral Maxillofac Surg; 2006 Mar; 35(3):252-7. PubMed ID: 16280239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
